Status:
COMPLETED
Early Re-Intervention Experiment 2
Lead Sponsor:
Chestnut Health Systems
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Use Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.
Detailed Description
CONTEXT: While drug abuse is the 10th leading cause of mortality in the US, the disorder remains an orphan of the public health care system. Unlike cancer, diabetes, and other chronic diseases, the de...
Eligibility Criteria
Inclusion
- any substance use in the past 90 days
- any past-year symptoms of substance use disorders.
Exclusion
- under 18
- lived or planned to move outside Chicago within 12 months
- sentenced to a confined environment most of the next 12 months
- mandated to treatment because of a driving under the influence offense
- were not fluent in English or Spanish
- were cognitively unable to provide informed consent.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
446 Patients enrolled
Trial Details
Trial ID
NCT01153594
Start Date
February 1 2004
End Date
June 1 2009
Last Update
June 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chestnut Health Systems
Chicago, Illinois, United States, 60610